首页 | 本学科首页   官方微博 | 高级检索  
     


B cell repertoire in patients with a novel BTK mutation: expanding the spectrum of atypical X-linked agammaglobulinemia
Authors:Toker  Ori  Broides  Arnon  Lev  Atar  Simon  Amos J.  Megged  Orli  Shamriz  Oded  Tal  Yuval  Somech  Raz  Lee  Yu Nee  Nahum   Amit
Affiliation:1.Faculty of Medicine, The Allergy and Immunology Unit, Hebrew University of Jerusalem, Shaare Zedek Medical Center, 12 Bayit Street, 91031, Jerusalem, Israel
;2.Immunology Clinic, Soroka University Medical Center, Beer-Sheva, Israel
;3.Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel
;4.Pediatric Department A and the Immunology Service, Sackler” Faculty of Medicine, Jeffrey Modell Foundation Center; “Edmond and Lily Safra” Children’s Hospital, Sheba Medical Center, Tel Aviv University, Tel-Aviv, Israel
;5.Faculty of Medicine, The Pediatric Infectious Diseases Unit, Hebrew University of Jerusalem, Shaare Zedek Medical Center, Jerusalem, Israel
;6.The Lautenberg Center for Immunology and Cancer Research, Faculty of Medicine, Institute of Medical Research Israel-Canada, Hebrew University of Jerusalem, Jerusalem, Israel
;7.Allergy and Clinical Immunology Unit, Department of Medicine, Faculty of Medicine, Hadassah Medical Organization, Hebrew University of Jerusalem, Jerusalem, Israel
;8.Pediatrics Department A, Soroka University Medical Center, Beer Sheva, Israel
;
Abstract:Immunologic Research - X-linked agammaglobulinemia (XLA) is caused by mutations in the Bruton tyrosine kinase) BTK) gene. Affected patients have severely reduced amounts of circulating B cells....
Keywords:
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号